Ben Z. Stanger

38.9k total citations · 16 hit papers
153 papers, 22.3k citations indexed

About

Ben Z. Stanger is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ben Z. Stanger has authored 153 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 69 papers in Oncology and 43 papers in Surgery. Recurrent topics in Ben Z. Stanger's work include Pancreatic and Hepatic Oncology Research (43 papers), Pancreatic function and diabetes (33 papers) and Cancer Cells and Metastasis (23 papers). Ben Z. Stanger is often cited by papers focused on Pancreatic and Hepatic Oncology Research (43 papers), Pancreatic function and diabetes (33 papers) and Cancer Cells and Metastasis (23 papers). Ben Z. Stanger collaborates with scholars based in United States, Japan and China. Ben Z. Stanger's co-authors include Philip Leder, Andrew D. Rhim, Douglas A. Melton, Robert H. Vonderheide, Nicole M. Aiello, Nabeel Bardeesy, Yiwei Zong, Ronald A. DePinho, Aram F. Hezel and Gregory L. Beatty and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ben Z. Stanger

147 papers receiving 22.0k citations

Hit Papers

EMT and Dissemination Precede Pancreat... 1995 2026 2005 2015 2012 2014 1995 2006 1998 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EMT and Dissemination Precede Pancreatic Tumor Formation
    2012 1.6k citations Andrew D. Rhim, Gregory L. Beatty et al. profile →
  2. Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
    2014 1.5k citations Andrew D. Rhim, Ben Z. Stanger et al. profile →
  3. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
    1995 1.3k citations Ben Z. Stanger et al. profile →
  4. Genetics and biology of pancreatic ductal adenocarcinoma
    2006 1.2k citations Ben Z. Stanger et al. profile →
  5. The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
    1998 905 citations Ben Z. Stanger et al. profile →
  6. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
    1995 822 citations Ben Z. Stanger et al. profile →
  7. Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
    2012 727 citations Gregory L. Beatty, Andrew D. Rhim et al. profile →
  8. Hippo Pathway Activity Influences Liver Cell Fate
    2014 635 citations Ben Z. Stanger et al. profile →
  9. Notch signaling controls multiple steps of pancreatic differentiation
    2003 625 citations Ben Z. Stanger et al. Proceedings of the National Academy of Sciences profile →
  10. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
    2018 474 citations Ravikanth Maddipati, Robert J. Norgard et al. profile →
  11. Robust cellular reprogramming occurs spontaneously during liver regeneration
    2013 360 citations Yiwei Zong, Ben Z. Stanger et al. profile →
  12. Adult Hepatocytes Are Generated by Self-Duplication Rather than Stem Cell Differentiation
    2014 320 citations Yiwei Zong, Ben Z. Stanger et al. profile →
  13. Pdx1 Maintains β Cell Identity and Function by Repressing an α Cell Program
    2014 312 citations Ben Z. Stanger et al. profile →
  14. Cellular Plasticity in Cancer
    2019 294 citations Salina Yuan, Robert J. Norgard et al. Cancer Discovery profile →
  15. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
    2021 208 citations Robert J. Norgard, Ben Z. Stanger et al. profile →
  16. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
    2022 205 citations Chi V. Dang, Ben Z. Stanger et al. profile →

Peers

Ben Z. Stanger
Owen J. Sansom United Kingdom
Atsushi Miyajima Japan
Akihiko Yoshimura Japan
Lena Claesson‐Welsh Sweden
Marc van de Wetering Netherlands
Tsvee Lapidot Israel
Glenn Merlino United States
Maaike van den Born Netherlands
Hong Wu United States
Jacques J. Peschon United States
Owen J. Sansom United Kingdom
Ben Z. Stanger
Citations per year, relative to Ben Z. Stanger Ben Z. Stanger (= 1×) peers Owen J. Sansom

Countries citing papers authored by Ben Z. Stanger

Since Specialization
Citations

This map shows the geographic impact of Ben Z. Stanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Z. Stanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Z. Stanger more than expected).

Fields of papers citing papers by Ben Z. Stanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Z. Stanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Z. Stanger. The network helps show where Ben Z. Stanger may publish in the future.

Co-authorship network of co-authors of Ben Z. Stanger

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Z. Stanger. A scholar is included among the top collaborators of Ben Z. Stanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Z. Stanger. Ben Z. Stanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahn, Benjamin, Raymond W.S. Ng, Il‐Kyu Kim, et al.. (2025). Intrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis. Cancer Discovery. 15(9). 1949–1968.
2.
Eccleston, Jason, Ofra Sabag, Jonathan Sussman, et al.. (2024). Transdifferentiation occurs without resetting development-specific DNA methylation, a key determinant of full-function cell identity. Proceedings of the National Academy of Sciences. 121(39). e2411352121–e2411352121. 5 indexed citations
3.
Markosyan, Nune, Il‐Kyu Kim, Nikhil Joshi, et al.. (2024). Pivotal roles for cancer cell–intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity. JCI Insight. 9(21). 3 indexed citations
4.
Katsuda, Takeshi, Jonathan Sussman, Kenneth S. Zaret, & Ben Z. Stanger. (2024). The yin and yang of pioneer transcription factors: Dual roles in repression and activation. BioEssays. 46(10). e2400138–e2400138. 5 indexed citations
5.
Sussman, Jonathan, Samantha B. Kemp, Daniel Traum, et al.. (2024). Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer. Cancer Research. 84(14). 2364–2376. 8 indexed citations
6.
Pitarresi, Jason R. & Ben Z. Stanger. (2023). Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine. 14(6). a041389–a041389. 4 indexed citations
7.
Li, Qinglan, Michelle Cicchini, Katherine R. Doerig, et al.. (2023). p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism. Nature Communications. 14(1). 4403–4403. 8 indexed citations
8.
Sela, Yogev, Jinyang Li, Robert J. Norgard, et al.. (2022). Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. Cancer Research. 82(10). 1890–1908. 12 indexed citations
9.
Cho, Christina, Jinyun Chen, Farima Zahedi, et al.. (2022). Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells. Molecular Cancer Research. 21(3). 228–239. 15 indexed citations
10.
Yang, Zijian, Michael J. LaRiviere, Jina Ko, et al.. (2020). A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 26(13). 3248–3258. 87 indexed citations
11.
Chandrakesan, Parthasarathy, Janani Panneerselvam, Randal May, et al.. (2020). DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization. Molecular Cancer Therapeutics. 19(7). 1539–1549. 27 indexed citations
12.
Li, Jinyang, Salina Yuan, Robert J. Norgard, et al.. (2020). Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer. Cancer Discovery. 11(3). 736–753. 104 indexed citations
13.
Carrer, Alessandro, Sophie Trefely, Steven Zhao, et al.. (2019). Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis. Cancer Discovery. 9(3). 416–435. 227 indexed citations
14.
Ko, Jina, Neha Bhagwat, Taylor A. Black, et al.. (2018). miRNA Profiling of Magnetic Nanopore–Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer. Cancer Research. 78(13). 3688–3697. 70 indexed citations
15.
Balli, David, Andrew J. Rech, Ben Z. Stanger, & Robert H. Vonderheide. (2016). Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer. Clinical Cancer Research. 23(12). 3129–3138. 176 indexed citations
16.
Winograd, Rafael, Katelyn T. Byrne, Rebecca A. Evans, et al.. (2015). Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. Cancer Immunology Research. 3(4). 399–411. 345 indexed citations
17.
Maddipati, Ravikanth & Ben Z. Stanger. (2015). Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discovery. 5(10). 1086–1097. 211 indexed citations
18.
Zhang, Yaqing, Wei Yan, Meredith A. Collins, et al.. (2013). Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance. Cancer Research. 73(20). 6359–6374. 197 indexed citations
19.
Hanlon, Linda, Jacqueline L. Avila, Renée M. Demarest, et al.. (2010). Notch1 Functions as a Tumor Suppressor in a Model of K-ras–Induced Pancreatic Ductal Adenocarcinoma. Cancer Research. 70(11). 4280–4286. 127 indexed citations
20.
Zong, Yiwei, Archana Panikkar, Jie Xu, et al.. (2009). Notch signaling controls liver development by regulating biliary differentiation. Development. 136(10). 1727–1739. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Owen J. Sansom Breakdown of academic impact, for papers by Atsushi Miyajima Breakdown of academic impact, for papers by Akihiko Yoshimura Breakdown of academic impact, for papers by Lena Claesson‐Welsh Breakdown of academic impact, for papers by Marc van de Wetering Breakdown of academic impact, for papers by Tsvee Lapidot Breakdown of academic impact, for papers by Glenn Merlino Breakdown of academic impact, for papers by Maaike van den Born Breakdown of academic impact, for papers by Hong Wu Breakdown of academic impact, for papers by Jacques J. Peschon
Rankless by CCL
2026